These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 11351258)
1. Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model. Gariboldi MB; Ravizza R; Marras E; Perletti G; De Simone A; Piccinini F; Monti E Int J Oncol; 2001 Jun; 18(6):1245-9. PubMed ID: 11351258 [TBL] [Abstract][Full Text] [Related]
2. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2. Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780 [TBL] [Abstract][Full Text] [Related]
3. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis. Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329 [TBL] [Abstract][Full Text] [Related]
4. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells. Takemura H; Urasaki Y; Yoshida A; Fukushima T; Ueda T Cancer Res; 2001 Jan; 61(1):172-7. PubMed ID: 11196156 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993 [TBL] [Abstract][Full Text] [Related]
7. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs. Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2alpha down-regulation. Whitman SP; Civoli F; Daniel LW J Biol Chem; 1997 Sep; 272(38):23481-4. PubMed ID: 9295281 [TBL] [Abstract][Full Text] [Related]
10. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein. Bullock G; Ray S; Reed JC; Krajewski S; Ibrado AM; Huang Y; Bhalla K Leukemia; 1996 Nov; 10(11):1731-40. PubMed ID: 8892676 [TBL] [Abstract][Full Text] [Related]
11. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670 [TBL] [Abstract][Full Text] [Related]
12. miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis. Bai H; Cao Z; Deng C; Zhou L; Wang C J Cancer Res Clin Oncol; 2012 Apr; 138(4):595-602. PubMed ID: 22209977 [TBL] [Abstract][Full Text] [Related]
13. Effect of cytarabine and decitabine in combination in human leukemic cell lines. Qin T; Youssef EM; Jelinek J; Chen R; Yang AS; Garcia-Manero G; Issa JP Clin Cancer Res; 2007 Jul; 13(14):4225-32. PubMed ID: 17634552 [TBL] [Abstract][Full Text] [Related]
14. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells. Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016 [TBL] [Abstract][Full Text] [Related]
15. Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line. Nishi R; Yamauchi T; Negoro E; Takemura H; Ueda T Cancer Sci; 2013 Apr; 104(4):502-7. PubMed ID: 23320492 [TBL] [Abstract][Full Text] [Related]
16. [Effect of nimodipine on mechanisms of HL-60 cell apoptosis induced by cytarabine]. Sun LR; Gao BC; Pang XY; Lu Y; Li XR; Song AQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):72-5. PubMed ID: 17490525 [TBL] [Abstract][Full Text] [Related]
17. All-trans-retinoic acid increases cytosine arabinoside cytotoxicity in HL-60 human leukemia cells in spite of decreased cellular ara-CTP accumulation. Freund A; Rössig C; Lanvers C; Gescher A; Hohenlöchter B; Jürgens H; Boos J Ann Oncol; 1999 Mar; 10(3):335-8. PubMed ID: 10355579 [TBL] [Abstract][Full Text] [Related]
18. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells]. Lei XY; Zhang H; He DM Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735 [TBL] [Abstract][Full Text] [Related]
19. [A novel bcl-2 antisense oligodeoxynucleotide F951 increases sensitivity of HL-60 cells to Ara-C]. Li DL; Lu LH; Chen YY; Lin ZX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):752-6. PubMed ID: 15631654 [TBL] [Abstract][Full Text] [Related]
20. [Ara-c induced apoptosis in human myeloid leukemia cell line HL-60]. Zhou J; Chen Y; Li C Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):107-10. PubMed ID: 10743072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]